Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood.

International journal of pediatric endocrinology

Quigley CA, Zagar AJ, Liu CC, Brown DM, Huseman C, Levitsky L, Repaske DR, Tsalikian E, Chipman JJ.
PMID: 23406437
Int J Pediatr Endocrinol. 2013 Feb 13;2013(1):6. doi: 10.1186/1687-9856-2013-6.

BACKGROUND: Many patients with childhood-onset growth hormone (GH) deficiency do not fulfill diagnostic criteria for GH deficiency (GHD) after attainment of adult height and may not require long-term GH treatment. Patients with history of idiopathic GHD (IGHD) pose the...

Cite
Quigley CA, Zagar AJ, Liu CC, et al. United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood. Int J Pediatr Endocrinol. 2013;2013(1):6doi: 10.1186/1687-9856-2013-6.
Quigley, C. A., Zagar, A. J., Liu, C. C., Brown, D. M., Huseman, C., Levitsky, L., Repaske, D. R., Tsalikian, E., & Chipman, J. J. (2013). United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood. International journal of pediatric endocrinology, 2013(1), 6. https://doi.org/10.1186/1687-9856-2013-6
Quigley, Charmian A, et al. "United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood." International journal of pediatric endocrinology vol. 2013,1 (2013): 6. doi: https://doi.org/10.1186/1687-9856-2013-6
Quigley CA, Zagar AJ, Liu CC, Brown DM, Huseman C, Levitsky L, Repaske DR, Tsalikian E, Chipman JJ. United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood. Int J Pediatr Endocrinol. 2013 Feb 13;2013(1):6. doi: 10.1186/1687-9856-2013-6. PMID: 23406437; PMCID: PMC3605263.
Copy Download .nbib Format: NLM
Characterization of the Genetic Diversity Present in a Diverse Sesame Landrace Collection Based on Phenotypic Traits and EST-SSR Markers Coupled With an HRM Analysis.

Plants (Basel, Switzerland)

Stavridou E, Lagiotis G, Kalaitzidou P, Grigoriadis I, Bosmali I, Tsaliki E, Tsiotsiou S, Kalivas A, Ganopoulos I, Madesis P.
PMID: 33808174
Plants (Basel). 2021 Mar 30;10(4). doi: 10.3390/plants10040656.

A selection of sesame (

Cite
Stavridou E, Lagiotis G, Kalaitzidou P, et al. Characterization of the Genetic Diversity Present in a Diverse Sesame Landrace Collection Based on Phenotypic Traits and EST-SSR Markers Coupled With an HRM Analysis. Plants (Basel). 2021;10(4)doi: 10.3390/plants10040656.
Stavridou, E., Lagiotis, G., Kalaitzidou, P., Grigoriadis, I., Bosmali, I., Tsaliki, E., Tsiotsiou, S., Kalivas, A., Ganopoulos, I., & Madesis, P. (2021). Characterization of the Genetic Diversity Present in a Diverse Sesame Landrace Collection Based on Phenotypic Traits and EST-SSR Markers Coupled With an HRM Analysis. Plants (Basel, Switzerland), 10(4), . https://doi.org/10.3390/plants10040656
Stavridou, Evangelia, et al. "Characterization of the Genetic Diversity Present in a Diverse Sesame Landrace Collection Based on Phenotypic Traits and EST-SSR Markers Coupled With an HRM Analysis." Plants (Basel, Switzerland) vol. 10,4 (2021). doi: https://doi.org/10.3390/plants10040656
Stavridou E, Lagiotis G, Kalaitzidou P, Grigoriadis I, Bosmali I, Tsaliki E, Tsiotsiou S, Kalivas A, Ganopoulos I, Madesis P. Characterization of the Genetic Diversity Present in a Diverse Sesame Landrace Collection Based on Phenotypic Traits and EST-SSR Markers Coupled With an HRM Analysis. Plants (Basel). 2021 Mar 30;10(4). doi: 10.3390/plants10040656. PMID: 33808174; PMCID: PMC8066031.
Copy Download .nbib Format: NLM
Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study.

BMC medicine

Sampson D, Yager TD, Fox B, Shallcross L, McHugh L, Seldon T, Rapisarda A, Hendriks RA, Brandon RB, Navalkar K, Simpson N, Stafford S, Gil E, Venturini C, Tsaliki E, Roe J, Chain B, Noursadeghi M.
PMID: 32690014
BMC Med. 2020 Jul 21;18(1):185. doi: 10.1186/s12916-020-01653-3.

BACKGROUND: There is an urgent need to develop biomarkers that stratify risk of bacterial infection in order to support antimicrobial stewardship in emergency hospital admissions.METHODS: We used computational machine learning to derive a rule-out blood transcriptomic signature of bacterial...

Cite
Sampson D, Yager TD, Fox B, et al. Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study. BMC Med. 2020;18(1):185doi: 10.1186/s12916-020-01653-3.
Sampson, D., Yager, T. D., Fox, B., Shallcross, L., McHugh, L., Seldon, T., Rapisarda, A., Hendriks, R. A., Brandon, R. B., Navalkar, K., Simpson, N., Stafford, S., Gil, E., Venturini, C., Tsaliki, E., Roe, J., Chain, B., & Noursadeghi, M. (2020). Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study. BMC medicine, 18(1), 185. https://doi.org/10.1186/s12916-020-01653-3
Sampson, Dayle, et al. "Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study." BMC medicine vol. 18,1 (2020): 185. doi: https://doi.org/10.1186/s12916-020-01653-3
Sampson D, Yager TD, Fox B, Shallcross L, McHugh L, Seldon T, Rapisarda A, Hendriks RA, Brandon RB, Navalkar K, Simpson N, Stafford S, Gil E, Venturini C, Tsaliki E, Roe J, Chain B, Noursadeghi M. Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study. BMC Med. 2020 Jul 21;18(1):185. doi: 10.1186/s12916-020-01653-3. PMID: 32690014; PMCID: PMC7372897.
Copy Download .nbib Format: NLM
Whole-genome resequencing of .

Horticulture research

Xanthopoulou A, Montero-Pau J, Mellidou I, Kissoudis C, Blanca J, Picó B, Tsaballa A, Tsaliki E, Dalakouras A, Paris HS, Ganopoulou M, Moysiadis T, Osathanunkul M, Tsaftaris A, Madesis P, Kalivas A, Ganopoulos I.
PMID: 31645952
Hortic Res. 2019 Aug 11;6:94. doi: 10.1038/s41438-019-0176-9. eCollection 2019.

No abstract available.

Cite
Xanthopoulou A, Montero-Pau J, Mellidou I, et al. Whole-genome resequencing of . Hortic Res. 2019;6:94doi: 10.1038/s41438-019-0176-9.
Xanthopoulou, A., Montero-Pau, J., Mellidou, I., Kissoudis, C., Blanca, J., Picó, B., Tsaballa, A., Tsaliki, E., Dalakouras, A., Paris, H. S., Ganopoulou, M., Moysiadis, T., Osathanunkul, M., Tsaftaris, A., Madesis, P., Kalivas, A., & Ganopoulos, I. (2019). Whole-genome resequencing of . Horticulture research, 694. https://doi.org/10.1038/s41438-019-0176-9
Xanthopoulou, Aliki, et al. "Whole-genome resequencing of ." Horticulture research vol. 6 (2019): 94. doi: https://doi.org/10.1038/s41438-019-0176-9
Xanthopoulou A, Montero-Pau J, Mellidou I, Kissoudis C, Blanca J, Picó B, Tsaballa A, Tsaliki E, Dalakouras A, Paris HS, Ganopoulou M, Moysiadis T, Osathanunkul M, Tsaftaris A, Madesis P, Kalivas A, Ganopoulos I. Whole-genome resequencing of . Hortic Res. 2019 Aug 11;6:94. doi: 10.1038/s41438-019-0176-9. eCollection 2019. PMID: 31645952; PMCID: PMC6804688.
Copy Download .nbib Format: NLM
Human plasma-derived alpha.

Pediatric diabetes

Lagarde WH, Courtney KL, Reiner B, Steinmann K, Tsalikian E, Willi SM.
PMID: 33244872
Pediatr Diabetes. 2021 Mar;22(2):192-201. doi: 10.1111/pedi.13162. Epub 2020 Dec 13.

BACKGROUND: While circulating levels of alphaPARTICIPANTS: Seventy-six participants (aged 6-35 years) were randomized at 25 centers within 3 months of T1DM diagnosis.METHODS: A Phase II, multicenter, partially blinded, placebo-controlled, proof-of-concept study evaluating four dosing regimens of alphaRESULTS: Infusions were...

Cite
Lagarde WH, Courtney KL, Reiner B, et al. Human plasma-derived alpha. Pediatr Diabetes. 2020;22(2):192-201doi: 10.1111/pedi.13162.
Lagarde, W. H., Courtney, K. L., Reiner, B., Steinmann, K., Tsalikian, E., & Willi, S. M. (2021). Human plasma-derived alpha. Pediatric diabetes, 22(2), 192-201. https://doi.org/10.1111/pedi.13162
Lagarde, William H, et al. "Human plasma-derived alpha." Pediatric diabetes vol. 22,2 (2021): 192-201. doi: https://doi.org/10.1111/pedi.13162
Lagarde WH, Courtney KL, Reiner B, Steinmann K, Tsalikian E, Willi SM. Human plasma-derived alpha. Pediatr Diabetes. 2021 Mar;22(2):192-201. doi: 10.1111/pedi.13162. Epub 2020 Dec 13. PMID: 33244872; PMCID: PMC7984376.
Copy Download .nbib Format: NLM
A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes.

Journal of the Endocrine Society

Laffel LM, Aleppo G, Buckingham BA, Forlenza GP, Rasbach LE, Tsalikian E, Weinzimer SA, Harris DR.
PMID: 29344578
J Endocr Soc. 2017 Nov 20;1(12):1461-1476. doi: 10.1210/js.2017-00389. eCollection 2017 Dec 01.

After assessing previously published methods, we developed a practical approach to adjusting insulin doses using rtCGM trend arrows in pediatric patients with diabetes.

Cite
Laffel LM, Aleppo G, Buckingham BA, et al. A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes. J Endocr Soc. 2017;1(12):1461-1476doi: 10.1210/js.2017-00389.
Laffel, L. M., Aleppo, G., Buckingham, B. A., Forlenza, G. P., Rasbach, L. E., Tsalikian, E., Weinzimer, S. A., & Harris, D. R. (2017). A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes. Journal of the Endocrine Society, 1(12), 1461-1476. https://doi.org/10.1210/js.2017-00389
Laffel, Lori M, et al. "A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes." Journal of the Endocrine Society vol. 1,12 (2017): 1461-1476. doi: https://doi.org/10.1210/js.2017-00389
Laffel LM, Aleppo G, Buckingham BA, Forlenza GP, Rasbach LE, Tsalikian E, Weinzimer SA, Harris DR. A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes. J Endocr Soc. 2017 Nov 20;1(12):1461-1476. doi: 10.1210/js.2017-00389. eCollection 2017 Dec 01. PMID: 29344578; PMCID: PMC5760209.
Copy Download .nbib Format: NLM
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.

JCI insight

Greenbaum CJ, Serti E, Lambert K, Weiner LJ, Kanaparthi S, Lord S, Gitelman SE, Wilson DM, Gaglia JL, Griffin KJ, Russell WE, Raskin P, Moran A, Willi SM, Tsalikian E, DiMeglio LA, Herold KC, Moore WV, Goland R, Harris M, Craig ME, Schatz DA, Baidal DA, Rodriguez H, Utzschneider KM, Nel HJ, Soppe CL, Boyle KD, Cerosaletti K, Keyes-Elstein L, Long SA, Thomas R, McNamara JG, Buckner JH, Sanda S.
PMID: 34747368
JCI Insight. 2021 Nov 08;6(21). doi: 10.1172/jci.insight.150074.

BackgroundIL-6 receptor (IL-6R) signaling drives development of T cell populations important to type 1 diabetes pathogenesis. We evaluated whether blockade of IL-6R with monoclonal antibody tocilizumab would slow loss of residual β cell function in newly diagnosed type 1...

Cite
Greenbaum CJ, Serti E, Lambert K, et al. IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes. JCI Insight. 2021;6(21)doi: 10.1172/jci.insight.150074.
Greenbaum, C. J., Serti, E., Lambert, K., Weiner, L. J., Kanaparthi, S., Lord, S., Gitelman, S. E., Wilson, D. M., Gaglia, J. L., Griffin, K. J., Russell, W. E., Raskin, P., Moran, A., Willi, S. M., Tsalikian, E., DiMeglio, L. A., Herold, K. C., Moore, W. V., Goland, R., Harris, M., Craig, M. E., Schatz, D. A., Baidal, D. A., Rodriguez, H., Utzschneider, K. M., Nel, H. J., Soppe, C. L., Boyle, K. D., Cerosaletti, K., Keyes-Elstein, L., Long, S. A., Thomas, R., McNamara, J. G., Buckner, J. H., Sanda, S. (2021). IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes. JCI insight, 6(21), . https://doi.org/10.1172/jci.insight.150074
Greenbaum, Carla J, et al. "IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes." JCI insight vol. 6,21 (2021). doi: https://doi.org/10.1172/jci.insight.150074
Greenbaum CJ, Serti E, Lambert K, Weiner LJ, Kanaparthi S, Lord S, Gitelman SE, Wilson DM, Gaglia JL, Griffin KJ, Russell WE, Raskin P, Moran A, Willi SM, Tsalikian E, DiMeglio LA, Herold KC, Moore WV, Goland R, Harris M, Craig ME, Schatz DA, Baidal DA, Rodriguez H, Utzschneider KM, Nel HJ, Soppe CL, Boyle KD, Cerosaletti K, Keyes-Elstein L, Long SA, Thomas R, McNamara JG, Buckner JH, Sanda S. IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes. JCI Insight. 2021 Nov 08;6(21). doi: 10.1172/jci.insight.150074. PMID: 34747368; PMCID: PMC8663550.
Copy Download .nbib Format: NLM
Correction to: Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study.

BMC medicine

Sampson D, Yager TD, Fox B, Shallcross L, McHugh L, Seldon T, Rapisarda A, Hendriks RA, Brandon RB, Navalkar K, Simpson N, Stafford S, Gil E, Venturini C, Tsaliki E, Roe J, Chain B, Noursadeghi M.
PMID: 32919476
BMC Med. 2020 Sep 12;18(1):293. doi: 10.1186/s12916-020-01756-x.

An amendment to this paper has been published and can be accessed via the original article.

Cite
Sampson D, Yager TD, Fox B, et al. Correction to: Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study. BMC Med. 2020;18(1):293doi: 10.1186/s12916-020-01756-x.
Sampson, D., Yager, T. D., Fox, B., Shallcross, L., McHugh, L., Seldon, T., Rapisarda, A., Hendriks, R. A., Brandon, R. B., Navalkar, K., Simpson, N., Stafford, S., Gil, E., Venturini, C., Tsaliki, E., Roe, J., Chain, B., & Noursadeghi, M. (2020). Correction to: Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study. BMC medicine, 18(1), 293. https://doi.org/10.1186/s12916-020-01756-x
Sampson, Dayle, et al. "Correction to: Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study." BMC medicine vol. 18,1 (2020): 293. doi: https://doi.org/10.1186/s12916-020-01756-x
Sampson D, Yager TD, Fox B, Shallcross L, McHugh L, Seldon T, Rapisarda A, Hendriks RA, Brandon RB, Navalkar K, Simpson N, Stafford S, Gil E, Venturini C, Tsaliki E, Roe J, Chain B, Noursadeghi M. Correction to: Blood transcriptomic discrimination of bacterial and viral infections in the emergency department: a multi-cohort observational validation study. BMC Med. 2020 Sep 12;18(1):293. doi: 10.1186/s12916-020-01756-x. PMID: 32919476; PMCID: PMC7488765.
Copy Download .nbib Format: NLM
Eyebrow Height Changes with Aging: A Systematic Review and Meta-analysis.

Plastic and reconstructive surgery. Global open

Asaad M, Kelarji AB, Jawhar CS, Banuelos J, Taslakian E, Wahood W, Vyas KS, Sharaf B.
PMID: 31942395
Plast Reconstr Surg Glob Open. 2019 Sep 30;7(9):e2433. doi: 10.1097/GOX.0000000000002433. eCollection 2019 Sep.

The eyebrows play an important role in emotional facial expressions, nonverbal communication, and facial esthetics. A comprehensive understanding of the mechanisms underlying eyebrow aging is vital in allowing plastic surgeons to appropriately address these age-related changes and to recreate...

Cite
Asaad M, Kelarji AB, Jawhar CS, et al. Eyebrow Height Changes with Aging: A Systematic Review and Meta-analysis. Plast Reconstr Surg Glob Open. 2019;7(9):e2433doi: 10.1097/GOX.0000000000002433.
Asaad, M., Kelarji, A. B., Jawhar, C. S., Banuelos, J., Taslakian, E., Wahood, W., Vyas, K. S., & Sharaf, B. (2019). Eyebrow Height Changes with Aging: A Systematic Review and Meta-analysis. Plastic and reconstructive surgery. Global open, 7(9), e2433. https://doi.org/10.1097/GOX.0000000000002433
Asaad, Malke, et al. "Eyebrow Height Changes with Aging: A Systematic Review and Meta-analysis." Plastic and reconstructive surgery. Global open vol. 7,9 (2019): e2433. doi: https://doi.org/10.1097/GOX.0000000000002433
Asaad M, Kelarji AB, Jawhar CS, Banuelos J, Taslakian E, Wahood W, Vyas KS, Sharaf B. Eyebrow Height Changes with Aging: A Systematic Review and Meta-analysis. Plast Reconstr Surg Glob Open. 2019 Sep 30;7(9):e2433. doi: 10.1097/GOX.0000000000002433. eCollection 2019 Sep. PMID: 31942395; PMCID: PMC6908395.
Copy Download .nbib Format: NLM
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.

JCI insight

Greenbaum CJ, Serti E, Lambert K, Weiner LJ, Kanaparthi S, Lord S, Gitelman SE, Wilson DM, Gaglia JL, Griffin KJ, Russell WE, Raskin P, Moran A, Willi SM, Tsalikian E, DiMeglio LA, Herold KC, Moore WV, Goland R, Harris M, Craig ME, Schatz DA, Baidal DA, Rodriguez H, Utzschneider KM, Nel HJ, Soppe CL, Boyle KD, Cerosaletti K, Keyes-Elstein L, Long SA, Thomas R, McNamara JG, Buckner JH, Sanda S.
PMID: 34747368
JCI Insight. 2021 Nov 08;6(21). doi: 10.1172/jci.insight.150074.

BackgroundIL-6 receptor (IL-6R) signaling drives development of T cell populations important to type 1 diabetes pathogenesis. We evaluated whether blockade of IL-6R with monoclonal antibody tocilizumab would slow loss of residual β cell function in newly diagnosed type 1...

Cite
Greenbaum CJ, Serti E, Lambert K, et al. IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes. JCI Insight. 2021;6(21)doi: 10.1172/jci.insight.150074.
Greenbaum, C. J., Serti, E., Lambert, K., Weiner, L. J., Kanaparthi, S., Lord, S., Gitelman, S. E., Wilson, D. M., Gaglia, J. L., Griffin, K. J., Russell, W. E., Raskin, P., Moran, A., Willi, S. M., Tsalikian, E., DiMeglio, L. A., Herold, K. C., Moore, W. V., Goland, R., Harris, M., Craig, M. E., Schatz, D. A., Baidal, D. A., Rodriguez, H., Utzschneider, K. M., Nel, H. J., Soppe, C. L., Boyle, K. D., Cerosaletti, K., Keyes-Elstein, L., Long, S. A., Thomas, R., McNamara, J. G., Buckner, J. H., Sanda, S. (2021). IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes. JCI insight, 6(21), . https://doi.org/10.1172/jci.insight.150074
Greenbaum, Carla J, et al. "IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes." JCI insight vol. 6,21 (2021). doi: https://doi.org/10.1172/jci.insight.150074
Greenbaum CJ, Serti E, Lambert K, Weiner LJ, Kanaparthi S, Lord S, Gitelman SE, Wilson DM, Gaglia JL, Griffin KJ, Russell WE, Raskin P, Moran A, Willi SM, Tsalikian E, DiMeglio LA, Herold KC, Moore WV, Goland R, Harris M, Craig ME, Schatz DA, Baidal DA, Rodriguez H, Utzschneider KM, Nel HJ, Soppe CL, Boyle KD, Cerosaletti K, Keyes-Elstein L, Long SA, Thomas R, McNamara JG, Buckner JH, Sanda S. IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes. JCI Insight. 2021 Nov 08;6(21). doi: 10.1172/jci.insight.150074. PMID: 34747368.
Copy Download .nbib Format: NLM
IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes.

JCI insight

Greenbaum CJ, Serti E, Lambert K, Weiner LJ, Kanaparthi S, Lord S, Gitelman SE, Wilson DM, Gaglia JL, Griffin KJ, Russell WE, Raskin P, Moran A, Willi SM, Tsalikian E, DiMeglio LA, Herold KC, Moore WV, Goland R, Harris M, Craig ME, Schatz DA, Baidal DA, Rodriguez H, Utzschneider KM, Nel HJ, Soppe CL, Boyle KD, Cerosaletti K, Keyes-Elstein L, Long SA, Thomas R, McNamara JG, Buckner JH, Sanda S.
PMID: 34747368
JCI Insight. 2021 Nov 08;6(21). doi: 10.1172/jci.insight.150074.

BackgroundIL-6 receptor (IL-6R) signaling drives development of T cell populations important to type 1 diabetes pathogenesis. We evaluated whether blockade of IL-6R with monoclonal antibody tocilizumab would slow loss of residual β cell function in newly diagnosed type 1...

Cite
Greenbaum CJ, Serti E, Lambert K, et al. IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes. JCI Insight. 2021;6(21)doi: 10.1172/jci.insight.150074.
Greenbaum, C. J., Serti, E., Lambert, K., Weiner, L. J., Kanaparthi, S., Lord, S., Gitelman, S. E., Wilson, D. M., Gaglia, J. L., Griffin, K. J., Russell, W. E., Raskin, P., Moran, A., Willi, S. M., Tsalikian, E., DiMeglio, L. A., Herold, K. C., Moore, W. V., Goland, R., Harris, M., Craig, M. E., Schatz, D. A., Baidal, D. A., Rodriguez, H., Utzschneider, K. M., Nel, H. J., Soppe, C. L., Boyle, K. D., Cerosaletti, K., Keyes-Elstein, L., Long, S. A., Thomas, R., McNamara, J. G., Buckner, J. H., Sanda, S. (2021). IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes. JCI insight, 6(21), . https://doi.org/10.1172/jci.insight.150074
Greenbaum, Carla J, et al. "IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes." JCI insight vol. 6,21 (2021). doi: https://doi.org/10.1172/jci.insight.150074
Greenbaum CJ, Serti E, Lambert K, Weiner LJ, Kanaparthi S, Lord S, Gitelman SE, Wilson DM, Gaglia JL, Griffin KJ, Russell WE, Raskin P, Moran A, Willi SM, Tsalikian E, DiMeglio LA, Herold KC, Moore WV, Goland R, Harris M, Craig ME, Schatz DA, Baidal DA, Rodriguez H, Utzschneider KM, Nel HJ, Soppe CL, Boyle KD, Cerosaletti K, Keyes-Elstein L, Long SA, Thomas R, McNamara JG, Buckner JH, Sanda S. IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes. JCI Insight. 2021 Nov 08;6(21). doi: 10.1172/jci.insight.150074. PMID: 34747368; PMCID: PMC8663550.
Copy Download .nbib Format: NLM
Inter-individual methylation variability in differentially methylated regions between maternal whole blood and first trimester CVS.

Molecular cytogenetics

Ioannides M, Papageorgiou EA, Keravnou A, Tsaliki E, Spyrou C, Hadjidaniel M, Sismani C, Koumbaris G, Patsalis PC.
PMID: 25426166
Mol Cytogenet. 2014 Nov 01;7(1):73. doi: 10.1186/s13039-014-0073-8. eCollection 2014.

BACKGROUND: DNA methylation is the most studied form of epigenetic regulation, a process by which chromatin composition and transcription factor binding is altered to influence tissue specific gene expression and differentiation. Such tissue specific methylation patterns are investigated as...

Cite
Ioannides M, Papageorgiou EA, Keravnou A, et al. Inter-individual methylation variability in differentially methylated regions between maternal whole blood and first trimester CVS. Mol Cytogenet. 2014;7(1):73doi: 10.1186/s13039-014-0073-8.
Ioannides, M., Papageorgiou, E. A., Keravnou, A., Tsaliki, E., Spyrou, C., Hadjidaniel, M., Sismani, C., Koumbaris, G., & Patsalis, P. C. (2014). Inter-individual methylation variability in differentially methylated regions between maternal whole blood and first trimester CVS. Molecular cytogenetics, 7(1), 73. https://doi.org/10.1186/s13039-014-0073-8
Ioannides, Marios, et al. "Inter-individual methylation variability in differentially methylated regions between maternal whole blood and first trimester CVS." Molecular cytogenetics vol. 7,1 (2014): 73. doi: https://doi.org/10.1186/s13039-014-0073-8
Ioannides M, Papageorgiou EA, Keravnou A, Tsaliki E, Spyrou C, Hadjidaniel M, Sismani C, Koumbaris G, Patsalis PC. Inter-individual methylation variability in differentially methylated regions between maternal whole blood and first trimester CVS. Mol Cytogenet. 2014 Nov 01;7(1):73. doi: 10.1186/s13039-014-0073-8. eCollection 2014. PMID: 25426166; PMCID: PMC4243368.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries